Boston Scientific (BSX)
(Real Time Quote from BATS)
$97.98 USD
-1.00 (-1.01%)
Updated Sep 17, 2025 10:32 AM ET
2-Buy of 5 2
D Value B Growth C Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, Boston Scientific Corporation has a market cap of $146.66B, which represents its share price of $98.98 multiplied by its outstanding shares number of 1.48B. As a large-cap company, BSX's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
BSX 97.98 -1.00(-1.01%)
Will BSX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for BSX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BSX
CAH Strengthens Distribution With New Consumer Health Logistics Hub
GEHC Expands Women's Health Portfolio With AI-Enabled Voluson
BSX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year?
Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors
Reasons to Retain Avanos Medical Stock in Your Portfolio Now
Other News for BSX
BSX forms Lower Bollinger Band Walk on September 16
Noteworthy Tuesday Option Activity: BSX, FDX, PYPL
Is BSX heading for a slide? Fell Below 200 Day Moving Average shows up after sliding 2.77%
Interesting BSX Put And Call Options For January 2028
Boston Scientific’s Strong Growth Prospects and Strategic Initiatives Reinforce Buy Rating